The strength in our findings regarding hepatic steatosis and insulin sensitivity is the use of several insulin sensitivity indices, recognizing that HOMA2S primarily is an insulin sensitivity-surrogate evaluating NAFLD for patients without T2D [46]. Here, INS is linked to fatty liver disease.